These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35419842)

  • 21. Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.
    Mori F; Caffarelli C; Caimmi S; Bottau P; Liotti L; Franceschini F; Cardinale F; Bernardini R; Crisafulli G; Saretta F; Novembre E
    Acta Biomed; 2019 Jan; 90(3-S):66-79. PubMed ID: 30830064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Uncommon Presentation of DRESS Syndrome Secondary to Leflunomide Use: A Case Report.
    Rao S; Sunkara A; Srivastava N; Sampat P; Ramos C; Albert E
    J Investig Med High Impact Case Rep; 2021; 9():2324709621997282. PubMed ID: 33629602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress).
    Hollingsworth P; Paci K; Evans M; Miedema J; Morrell DS
    Pediatr Dermatol; 2020 Sep; 37(5):947-949. PubMed ID: 32524672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
    Gottlieb M; Figlewicz MR; Rabah W; Buddan D; Long B
    Am J Emerg Med; 2022 Jun; 56():1-6. PubMed ID: 35338896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bullous drug eruption with Nigella sativa oil].
    Gelot P; Bara-Passot C; Gimenez-Arnau E; Beneton N; Maillard H; Celerier P
    Ann Dermatol Venereol; 2012 Apr; 139(4):287-91. PubMed ID: 22482483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug reaction with eosinophilia and systemic symptoms syndrome.
    Spriet S; Banks TA
    Allergy Asthma Proc; 2015; 36(6):501-5. PubMed ID: 26534757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) with concomitant acute chikungunya virus infection: possible role of new viral trigger.
    Sil A; Bhattacharjee MS; Chandra A; Pramanik JD
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34642219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
    Nylund M; Vuorinen T; Airas L
    Mult Scler Relat Disord; 2020 Jul; 42():102058. PubMed ID: 32208345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimetazidine, a hitherto unreported cause of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
    Singh S; Khurana A; Muddebihal A; Jangra M
    Contact Dermatitis; 2021 Mar; 84(3):208-210. PubMed ID: 33034892
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Probably Related to Cefpodoxime: A Case Report.
    Babu T; Panachiyil GM; Sebastian J; Shastry V
    J Pharm Pract; 2021 Feb; 34(1):163-165. PubMed ID: 31382812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of topical black seed oil in the treatment of allergic rhinitis.
    Alsamarai AM; Abdulsatar M; Ahmed Alobaidi AH
    Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):75-82. PubMed ID: 23855426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Children: A Case Report.
    Mattoussi N; Ben Mansour A; Essadam L; Guedri R; Fitouri Z; Ben Becher S
    J Investig Allergol Clin Immunol; 2017; 27(2):144-146. PubMed ID: 28398207
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic management of DRESS: a retrospective study of 38 cases.
    Funck-Brentano E; Duong TA; Bouvresse S; Bagot M; Wolkenstein P; Roujeau JC; Chosidow O; Valeyrie-Allanore L
    J Am Acad Dermatol; 2015 Feb; 72(2):246-52. PubMed ID: 25592341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
    Ganeshanandan L; Lucas M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of drug reaction with eosinophilia and systemic symptoms with ranitidine patch testing.
    Teo YX; Ardern-Jones MR
    Contact Dermatitis; 2021 Apr; 84(4):278-279. PubMed ID: 33104238
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.
    Cho YT; Yang CW; Chu CY
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis.
    Abdel-Wahhab MA; Aly SE
    J Appl Toxicol; 2005; 25(3):218-23. PubMed ID: 15856529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.